Lubiprostone as a potential therapeutic agent to improve intestinal permeability and prevent the development of atherosclerosis in apolipoprotein E-deficient mice

por Arakawa, Kentaro, Ishigami, Tomoaki, Nakai-Sugiyama, Michiko, Chen, Lin, Doi, Hiroshi, Kino, Tabito, Minegishi, Shintaro, Saigoh-Teranaka, Sae, Sasaki-Nakashima, Rie, Hibi, Kiyoshi, Kimura, Kazuo, Tamura, Kouichi
Publicado 2019